Guggenheim Capital LLC Sells 2,419 Shares of DaVita Inc. (NYSE:DVA)

Guggenheim Capital LLC lessened its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 33.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,813 shares of the company's stock after selling 2,419 shares during the quarter. Guggenheim Capital LLC's holdings in DaVita were worth $720,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. SBI Securities Co. Ltd. acquired a new stake in shares of DaVita during the 4th quarter valued at $41,000. Canada Post Corp Registered Pension Plan acquired a new stake in DaVita during the fourth quarter valued at $55,000. Venturi Wealth Management LLC grew its stake in DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock valued at $61,000 after purchasing an additional 152 shares in the last quarter. Versant Capital Management Inc increased its position in DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after purchasing an additional 169 shares during the last quarter. Finally, Blue Trust Inc. increased its position in DaVita by 39.7% in the 4th quarter. Blue Trust Inc. now owns 461 shares of the company's stock worth $76,000 after purchasing an additional 131 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Stock Performance

Shares of NYSE:DVA traded up $0.01 during midday trading on Friday, hitting $139.57. The company's stock had a trading volume of 600,714 shares, compared to its average volume of 841,722. DaVita Inc. has a fifty-two week low of $131.27 and a fifty-two week high of $179.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The stock has a market capitalization of $11.17 billion, a price-to-earnings ratio of 13.00, a PEG ratio of 1.07 and a beta of 1.04. The stock's 50 day simple moving average is $146.50 and its 200 day simple moving average is $155.24.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, research analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Sanford C. Bernstein set a $184.00 price target on DaVita in a research note on Friday, February 21st. StockNews.com upgraded shares of DaVita from a "hold" rating to a "buy" rating in a research note on Friday. Cowen restated a "hold" rating on shares of DaVita in a report on Tuesday, February 18th. Finally, Barclays increased their target price on shares of DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, DaVita currently has an average rating of "Hold" and an average target price of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.